4//SEC Filing
Robichaud Albert 4
Accession 0001562180-21-001127
CIK 0001597553other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:02 PM ET
Size
7.7 KB
Accession
0001562180-21-001127
Insider Transaction Report
Form 4
Robichaud Albert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-10+22,500→ 22,500 totalExercise: $82.27Exp: 2031-02-10→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The securities awarded on February 10, 2021 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,625 shares of common stock shall vest on the one year anniversary of February 10, 2021, with 16,875 shares vesting in 36 equal monthly installments thereafter.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0001612861
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:02 PM ET
- Size
- 7.7 KB